The Problem With Penotipic Screens in Pathology

The company recursion has knocked out every gene in the genome and measured, using computer vision, how the cel morphology changes. They hope to do essentially profile house cell morphology changes across knockouts of every gene on the guno. And so instead of building a different phenotypic screen for every disease one wants to explore, we want to do essentially profiles house cell morphology change over millions of molecules or thousands of sidokinds.